Top Markets
#1 MowCat MowCat +49.07%
#2 Velvet Velvet +36.37%
#3 Derive Derive +20.53%
#4 Quack AI Quack AI +19.75%
#5 Audiera Audiera +19.69%
#6 MarsCoin MarsCoin +16.65%
#7 Bermuda Shorts Bermuda Shorts +16.51%
#8 aPriori aPriori +15.29%
#9 Biconomy Biconomy +13.82%
#10 Geodnet Geodnet +12.49%
Coin of the day
MowCat MowCat
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
PharmaTher Holdings Ltd. PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd.

PHRM
Pozycja w akcjach #35372
PharmaTher Holdings Ltd. operates as a clinical-stage biotechnology firm,... PharmaTher Holdings Ltd. operates as a clinical-stage biotechnology firm, primarily focused on psychedelic compounds. It is dedicated to investigating, advancing, and bringing to market innovative applications, formulations, and administration techniques for psychedelics to treat a range of conditions including mental health disorders, neurological ailments, and chronic pain. A key asset in its development portfolio is an intravenous ketamine injection, currently undergoing Phase II and III clinical evaluations targeting indications such as Parkinson's disease, anesthesia/sedation, and amyotrophic lateral sclerosis (ALS). The company's pipeline further features a Ketamine Patch, which is progressing through Phase I and II clinical trials for the treatment of depression, various mental health conditions, complex regional pain syndrome (CRPS), and other pain-related disorders. Additionally, a Ketamine Pump is undergoing Phase II clinical assessment for use in mental health, pain management, and surgical/procedural settings. Beyond these, PharmaTher is actively developing PHARMAPATCH, an innovative microneedle patch designed for psychedelic drug delivery. The company has established strategic collaboration agreements with several partners, including LTS Lohmann Therapie-Systeme AG for developing a ketamine microneedle patch; Alcami Corporation for the advancement of ketamine injectables and infusions; BioRAE, Inc. for the development of ketamine pump technology; Revive Therapeutics Ltd. to develop a psilocybin microneedle patch; and Gesval S.A. for the development of patented continuous-flow process technology for synthesizing ketamine and its analogs. PharmaTher is also internally dedicated to creating its own proprietary wearable ketamine delivery system, intended for addressing mental health, neurological, and pain conditions. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Cena akcji
$0.04403621
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$4.01M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-85.68%
Kraj
CA
Handel PharmaTher Holdings Ltd. (PHRM)

Kategoria

Healthcare
Historia ceny akcji dla PharmaTher Holdings Ltd. (PHRM)
Najwyższa cena zamknięcia: $0.04 dnia 2026-08-01

Najniższa cena zamknięcia: $0.19 dnia 2021-04-01
Historia cen akcji firmy PharmaTher Holdings Ltd. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 12.84%
2025 -50.83%
2024 -2.63%
2023 216.44%
2022 -80.29%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE